ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Outset Medical Welcomes Jean-Olivier Racine as Chief Technology Officer

Former Head of Engineering and Science for Health AI at Amazon Web Services Joins Dialysis Technology Innovation Leader

Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a dialysis technology innovator, today announced the appointment of Jean-Olivier Racine as Chief Technology Officer. In this new role, Racine will oversee the strategic advancement of Outset’s product technology, amplifying the company’s data-driven innovation engine to further elevate the patient care experience and drive operating efficiencies for providers.

Racine joins Outset Medical with more than two decades of experience in the technology industry. Prior to joining Outset, he worked as the head of engineering and science for Amazon Web Services (AWS) Health AI where he managed Amazon Comprehend Medical, Amazon HealthLake and a variety of health services in development.

“Jean-Olivier’s knowledge of the development of high-scale and high-availability services for the storage of health data, such as HealthLake, is critical to the innovation initiatives we intend to pursue in order to empower patients and healthcare providers,” said Outset Medical CEO Leslie Trigg. “His background in designing scalable and performant cloud architectures for at-home health and consumer products, such as Amazon Halo and Fire TV, and in using machine learning for retrieving health insights from data, such as Comprehend Medical, will be invaluable as we continue to invent in ways that uplift the dialysis patient population.”

As the industry’s only hemodialysis technology cleared by the FDA for two-way wireless data transmission, Outset’s Tablo Hemodialysis System sends patient treatment data seamlessly to electronic medical record systems and also to TabloHub, a proprietary cloud-based provider portal that aggregates all patient and Tablo fleet records. At the same time, Tablo captures more than 500,000 machine performance data points after every treatment. That information is then used to fuel data analytics and machine learning algorithms that, in this new role, Racine will utilize to continually improve the technology, create service efficiencies and uncover new opportunities.

Racine spent almost ten years in a variety of Amazon leadership positions, including as the head of science and engineering for AWS Health AI, head of cloud services and Alexa for Halo, head of the Digital Media Catalog for Fire TV, and as the fluidity and performance lead for Kindle Fire tablets. Before joining Amazon, Racine spent more than a decade in software engineering for companies such as the Toronto Stock Exchange (TMX), NexGen Ergonomics, Versaterm and Canada’s Department of National Defense. Racine earned both his bachelor's degree in production automation engineering, health technologies and his master’s degree in engineering, health technologies from the Université du Québec - École de technologie supérieure.

“I was drawn to join Outset Medical because of the vast opportunity the dialysis industry presents, especially with regards to utilizing technology and AI for the development of new care modalities,” said Racine. “Throughout my career I have seen the progress the health tech industry has made as artificial intelligence, machine learning and the consumer driven digital experience has become a reality for numerous patient populations. I look forward to using my expertise to build upon the incredible strides Outset has already made with Tablo, and to create new efficiencies for patients and providers as we continue to move towards a tech-enabled future.”

About Outset Medical, Inc.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo™ Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.